185 related articles for article (PubMed ID: 36879117)
1. L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis.
Tabata S; Kojima Y; Sakamoto T; Igarashi K; Umetsu K; Ishikawa T; Hirayama A; Kajino-Sakamoto R; Sakamoto N; Yasumoto KI; Okano K; Suzuki Y; Yachida S; Aoki M; Soga T
Oncogene; 2023 Apr; 42(16):1294-1307. PubMed ID: 36879117
[TBL] [Abstract][Full Text] [Related]
2. L-2-Hydroxyglutarate Protects Against Cardiac Injury via Metabolic Remodeling.
He H; Mulhern RM; Oldham WM; Xiao W; Lin YD; Liao R; Loscalzo J
Circ Res; 2022 Sep; 131(7):562-579. PubMed ID: 36043417
[TBL] [Abstract][Full Text] [Related]
3. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.
Brüning A; Rahmeh M; Friese K
Mol Oncol; 2013 Dec; 7(6):1012-8. PubMed ID: 23916134
[TBL] [Abstract][Full Text] [Related]
4. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
Brinkley G; Nam H; Shim E; Kirkman R; Kundu A; Karki S; Heidarian Y; Tennessen JM; Liu J; Locasale JW; Guo T; Wei S; Gordetsky J; Johnson-Pais TL; Absher D; Rakheja D; Challa AK; Sudarshan S
Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32928875
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.
Lian N; Lin T; Liu W; Wang W; Li L; Sun S; Nyman JS; Yang X
J Biol Chem; 2012 Oct; 287(43):35975-84. PubMed ID: 22952236
[TBL] [Abstract][Full Text] [Related]
6. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Zhang ZJ; Wu QF; Ren AQ; Chen Q; Shi JZ; Li JP; Liu XY; Zhang ZJ; Tang YZ; Zhao Y; Yao NN; Zhang XY; Liu CP; Dong G; Zhao JX; Xu MJ; Yue YQ; Hu J; Sun F; Liu Y; Ao QL; Zhou FL; Wu H; Zhang TC; Zhu HC
Acta Pharmacol Sin; 2023 Nov; 44(11):2282-2295. PubMed ID: 37280363
[TBL] [Abstract][Full Text] [Related]
7. Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition.
Han S; Zhu L; Zhu Y; Meng Y; Li J; Song P; Yousafzai NA; Feng L; Chen M; Wang Y; Jin H; Wang X
Theranostics; 2021; 11(17):8464-8479. PubMed ID: 34373753
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.
O'Leary EM; Tian Y; Nigdelioglu R; Witt LJ; Cetin-Atalay R; Meliton AY; Woods PS; Kimmig LM; Sun KA; Gökalp GA; Mutlu GM; Hamanaka RB
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):601-612. PubMed ID: 32668192
[TBL] [Abstract][Full Text] [Related]
9. Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.
Le Y; Zhang S; Ni J; You Y; Luo K; Yu Y; Shen X
Cell Death Dis; 2018 Jun; 9(6):666. PubMed ID: 29867114
[TBL] [Abstract][Full Text] [Related]
10. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
11. Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways.
Li R; Zhou H; Li M; Mai Q; Fu Z; Jiang Y; Li C; Gao Y; Fan Y; Wu K; Costa CD; Sheng X; He Y; Li N
Cells; 2022 Jul; 11(14):. PubMed ID: 35883579
[TBL] [Abstract][Full Text] [Related]
12. PI3K signaling mediates diverse regulation of ATF4 expression for the survival of HK-2 cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2014 Feb; 88(2):403-14. PubMed ID: 24057571
[TBL] [Abstract][Full Text] [Related]
13. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
14. NMIIA promotes tumorigenesis and prevents chemosensitivity in colorectal cancer by activating AMPK/mTOR pathway.
Wang Z; Zhu Z; Li C; Zhang Y; Li Z; Sun S
Exp Cell Res; 2021 Jan; 398(1):112387. PubMed ID: 33220257
[TBL] [Abstract][Full Text] [Related]
15. Central activating transcription factor 4 (ATF4) regulates hepatic insulin resistance in mice via S6K1 signaling and the vagus nerve.
Zhang Q; Yu J; Liu B; Lv Z; Xia T; Xiao F; Chen S; Guo F
Diabetes; 2013 Jul; 62(7):2230-9. PubMed ID: 23454693
[TBL] [Abstract][Full Text] [Related]
16. Decreased ATF4 expression as a mechanism of acquired resistance to long-term amino acid limitation in cancer cells.
Mesclon F; Lambert-Langlais S; Carraro V; Parry L; Hainault I; Jousse C; Maurin AC; Bruhat A; Fafournoux P; Averous J
Oncotarget; 2017 Apr; 8(16):27440-27453. PubMed ID: 28460466
[TBL] [Abstract][Full Text] [Related]
17. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
Zhao L; Chen H; Zhang Q; Ma J; Hu H; Xu L
Cancer Chemother Pharmacol; 2022 May; 89(5):595-607. PubMed ID: 35312836
[TBL] [Abstract][Full Text] [Related]
18.
Krishnamoorthy GP; Davidson NR; Leach SD; Zhao Z; Lowe SW; Lee G; Landa I; Nagarajah J; Saqcena M; Singh K; Wendel HG; Dogan S; Tamarapu PP; Blenis J; Ghossein RA; Knauf JA; Rätsch G; Fagin JA
Cancer Discov; 2019 Feb; 9(2):264-281. PubMed ID: 30305285
[TBL] [Abstract][Full Text] [Related]
19. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
20. JNK contributes to the tumorigenic potential of human cholangiocarcinoma cells through the mTOR pathway regulated GRP78 induction.
Feng C; He K; Zhang C; Su S; Li B; Li Y; Duan CY; Chen S; Chen R; Liu Y; Li H; Wei M; Xia X; Dai R
PLoS One; 2014; 9(2):e90388. PubMed ID: 24587347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
